State Street Corp Molecular Templates, Inc. Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $3.43 $403,848 - $1.71 Million	-498,579 Reduced 77.99%	140,681 $128,000
Q1 2022 May 16, 2022	BUY	$2.27 - $4.13 $67,577 - $122,950	29,770 Added 4.88%	639,260 $2.21 Million
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $46,185 - $94,153	-13,705 Reduced 2.2%	609,490 $2.39 Million
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $91,306 - $124,164	15,797 Added 2.6%	623,195 $4.18 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $1.19 Million - $1.9 Million	152,465 Added 33.51%	607,398 $4.75 Million
Q1 2021 May 17, 2021	SELL	$9.33 - $14.05 $36,928 - $55,609	-3,958 Reduced 0.86%	454,933 $5.74 Million
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $68,213 - $98,378	8,044 Added 1.78%	458,891 $4.31 Million
Q3 2020 Nov 10, 2020	BUY	$9.99 - $14.41 $206,743 - $298,214	20,695 Added 4.81%	450,847 $4.92 Million
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $1.29 Million - $1.85 Million	104,814 Added 32.22%	430,152 $5.93 Million
Q1 2020 May 11, 2020	BUY	$11.31 - $18.26 $3.68 Million - $5.94 Million	325,338 New	325,338 $4.32 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.